Semax: Complete Research Guide & Chemical Profile | ACTH 4-10

Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH), specifically corresponding to the ACTH 4-10 sequence. With the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro and a molecular weight of 813.93 Da, this research compound has garnered significant attention in neuroscience laboratories worldwide.

Originally developed in Russia during the 1980s, Semax represents a modified version of the naturally occurring ACTH fragment. The peptide maintains high purity standards of ≥98% in research-grade preparations, making it suitable for controlled laboratory investigations into neuroprotective and cognitive enhancement mechanisms.

Research interest in Semax stems from its unique structural properties that allow it to cross the blood-brain barrier more effectively than its parent ACTH molecule. This characteristic has positioned it as a valuable tool for studying neuroplasticity, memory formation, and neuroprotective pathways in laboratory models.

Scientific investigation into Semax began in the 1980s at the Institute of Molecular Genetics of the Russian Academy of Sciences. Early research focused on understanding how synthetic ACTH fragments could influence cognitive processes and stress responses in laboratory settings.

Preclinical studies have demonstrated that Semax exhibits neuroprotective properties in various experimental models. Research published in neuroscience journals indicates that the peptide may influence brain-derived neurotrophic factor (BDNF) expression, potentially contributing to neuroplasticity mechanisms observed in laboratory studies.

Investigations into Semax's effects on learning and memory have utilized maze-based behavioral assessments in rodent models. These studies suggest that the peptide may enhance cognitive performance through modulation of neurotransmitter systems, particularly involving dopaminergic and serotonergic pathways.

Recent research has expanded to explore Semax's potential neuroprotective effects in models of cerebral ischemia and oxidative stress. Laboratory findings indicate that the peptide may help maintain cellular viability under conditions of metabolic stress, though these observations require further validation in controlled experimental settings.

Research suggests that Semax exerts its effects through multiple molecular pathways, primarily involving modulation of neurotrophic factor expression and neurotransmitter system regulation. Studies indicate that the peptide may influence BDNF levels, a key protein involved in neuronal survival and synaptic plasticity.

Laboratory investigations have revealed that Semax may interact with melanocortin receptors, particularly MC4 receptors, which are distributed throughout the central nervous system. This interaction appears to trigger downstream signaling cascades that influence neuronal excitability and synaptic transmission in experimental models.

The peptide's neuroprotective mechanisms may involve modulation of oxidative stress responses and maintenance of mitochondrial function. Research data suggests that Semax can influence cellular antioxidant systems, potentially protecting neurons from damage under experimental stress conditions.

Studies have also indicated that Semax may affect the expression of genes involved in neuroplasticity and cellular repair processes. These genomic effects appear to contribute to the peptide's observed influence on learning, memory consolidation, and neuronal adaptation in laboratory settings.

Semax exhibits specific chemical characteristics that are crucial for research applications. The peptide has a molecular weight of 813.93 Da and follows the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro. Research-grade Semax typically maintains purity levels of ≥98%, as verified through high-performance liquid chromatography (HPLC) analysis.

The peptide demonstrates a relatively short half-life of several minutes in biological systems, which has important implications for experimental design and timing in laboratory studies. This rapid metabolism necessitates careful consideration of experimental protocols and sampling timepoints in research applications.

Proper storage conditions are essential for maintaining Semax stability in laboratory settings. Lyophilized powder should be stored at -20°C in a dry environment, protected from light and moisture. Under these conditions, the peptide typically maintains stability for extended periods when unopened.

Once reconstituted, Semax solutions require refrigeration at 2-8°C and should be used within the timeframe specified by the manufacturer. Research laboratories should implement appropriate handling protocols to prevent contamination and ensure consistent experimental results.

Semax demonstrates good solubility in aqueous solutions, particularly in sterile water or phosphate-buffered saline commonly used in laboratory preparations. The peptide's stability can be influenced by pH, temperature, and exposure to light, requiring careful attention to preparation conditions.

Research indicates that Semax maintains optimal stability at physiological pH ranges, making it suitable for cell culture studies and in vitro experiments. However, extreme pH conditions or prolonged exposure to elevated temperatures may compromise peptide integrity and experimental validity.

Researchers seeking high-quality Semax for laboratory studies can find verified vendors and third-party tested batches through ChemVerify's comprehensive database. The platform provides detailed information about supplier verification, batch testing results, and quality assurance protocols to ensure research integrity.

ChemVerify's verification process includes assessment of peptide purity, identity confirmation through mass spectrometry, and evaluation of storage and shipping conditions. This thorough approach helps researchers obtain reliable Semax preparations for their experimental work. Visit /product/semax to explore verified sources and quality documentation.

<strong>What is the relationship between Semax and ACTH?</strong>

Semax is a synthetic analog derived from the ACTH 4-10 fragment. While maintaining structural similarities to the parent hormone, Semax has been modified to enhance stability and bioavailability for research applications.

<strong>How should Semax be reconstituted for laboratory use?</strong>

Research protocols typically involve reconstituting lyophilized Semax with sterile water or appropriate buffer solutions. The specific concentration and reconstitution method should follow established laboratory protocols and manufacturer guidelines.

<strong>What analytical methods are used to verify Semax purity?</strong>

High-performance liquid chromatography (HPLC) and mass spectrometry are the primary analytical methods used to confirm Semax identity and purity. These techniques provide accurate assessment of peptide quality for research applications.

<strong>What experimental models are commonly used in Semax research?</strong>

Research studies have utilized various experimental approaches including cell culture systems, rodent behavioral models, and neurochemical assays to investigate Semax's effects on cognitive function and neuroprotection.

<strong>How does Semax's short half-life affect experimental design?</strong>

The peptide's rapid metabolism requires careful timing of experimental procedures and sample collection. Researchers must consider pharmacokinetic properties when designing protocols to capture relevant biological effects.

<strong>What quality control measures are important for Semax research?</strong>

Essential quality control measures include verification of peptide identity, purity assessment, proper storage conditions, and appropriate handling protocols. Third-party testing documentation provides additional assurance of research material quality.

Explore detailed chemical profiles and research guides for compounds discussed in this article:

• BPC-157: Complete Research Guide → /learn/bpc-157
• TB-500: Complete Research Guide → /learn/tb-500

• Read more: RFK Jr. Signals Reversal of Peptide Ban: 14 of 19 Restricted Compounds May Return → https://www.chemverify.com/learn/rfk-jr-signals-reversal-of-peptide-ban-14-of-19-restricted-compounds-may-return
• Read more: AI-Guided High-Throughput Screening Accelerates Antimicrobial Peptide-Mimicking Polymer Discovery → https://www.chemverify.com/learn/ai-guided-antimicrobial-peptide-polymer-discovery
• Read more: Re-Engineering Insulin for Oral Delivery: Structural Modifications and Formulation Advances → https://www.chemverify.com/learn/insulin-oral-delivery-peptide-engineering
• Read more: Cyclic Lipopeptides: Biosurfactant Peptides as Next-Generation Drug Delivery Modulators → https://www.chemverify.com/learn/cyclic-lipopeptides-drug-delivery-modulators
• Read more: Microneedle-Delivered Peptide Decoy Receptors Show Promise in Psoriasis Treatment → https://www.chemverify.com/learn/microneedle-peptide-decoy-receptors-psoriasis